ES2086326T3 - Metodo para intensificar la quimiluminiscencia. - Google Patents

Metodo para intensificar la quimiluminiscencia.

Info

Publication number
ES2086326T3
ES2086326T3 ES90102835T ES90102835T ES2086326T3 ES 2086326 T3 ES2086326 T3 ES 2086326T3 ES 90102835 T ES90102835 T ES 90102835T ES 90102835 T ES90102835 T ES 90102835T ES 2086326 T3 ES2086326 T3 ES 2086326T3
Authority
ES
Spain
Prior art keywords
chemiluminescence
intensifying
optionally substituted
hydroxyphenyl
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90102835T
Other languages
English (en)
Inventor
Koichi Kondo
Takashi Sohda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Application granted granted Critical
Publication of ES2086326T3 publication Critical patent/ES2086326T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)

Abstract

UN METODO PARA MEJORA DE LA QUIMIOLUMINISCENCIA QUE UTILIZA UN COMPUESTO HETEROCICLICO DE LA FORMULA: EN LA QUE R1 ES UN OXIGENO O ATOMO SULFURICO O UN GRUPO IMINICO QUE SE SUSTITUYE OPCIONALMENTE POR UN 4-HIDROXIPENILO, Y R2, R3 Y R4 SON UN HIDROGENO O ATOMO ALOGENICO, UN RESIDUO DE HIDROCARBONO SUSTITUIDO OPCIONALMENTE, UN GRUPO HETEROCICLICO O SIMILAR EN UN SISTEMA DE LUMINISCENCIA.
ES90102835T 1989-02-14 1990-02-13 Metodo para intensificar la quimiluminiscencia. Expired - Lifetime ES2086326T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3472989 1989-02-14

Publications (1)

Publication Number Publication Date
ES2086326T3 true ES2086326T3 (es) 1996-07-01

Family

ID=12422407

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90102835T Expired - Lifetime ES2086326T3 (es) 1989-02-14 1990-02-13 Metodo para intensificar la quimiluminiscencia.

Country Status (6)

Country Link
US (1) US5106732A (es)
EP (1) EP0384271B1 (es)
AT (1) ATE137805T1 (es)
CA (1) CA2009925C (es)
DE (1) DE69026851T2 (es)
ES (1) ES2086326T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3025336B2 (ja) * 1990-04-30 2000-03-27 日立化成工業株式会社 改良された化学ルミネセント試薬および方法
CA2061189A1 (en) * 1991-05-24 1992-11-25 M. Hashem Akhavan-Tafti Chemiluminescent method and compositions
US5279940A (en) * 1992-08-03 1994-01-18 Eastman Kodak Company Chemiluminescent composition containing cationic surfactants or polymers and 4'-hydroxyacetanilide, test kits and their use in analytical methods
EP0650044A3 (en) * 1993-04-02 1996-06-19 Hitachi Chemical Co Ltd Analytical chemiluminescence method.
CA2130947C (en) 1993-11-12 2001-02-06 Robert E. Emmons Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents
AU697785B2 (en) 1994-07-19 1998-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Analytical element,composition and method using modified apo-horseradish peroxidase
JPH08136546A (ja) * 1994-11-15 1996-05-31 Bio Sensor Kenkyusho:Kk 物質分析法
US5801008A (en) * 1995-05-31 1998-09-01 Kyowa Medex Co., Ltd. Method of quantitative determination of peroxide, a peroxidation-active substance or a pyrazolopyridopyridazine derivative
US5811253A (en) * 1995-09-01 1998-09-22 Johnson & Johnson Clinical Diagnostics, Inc. Use of vanadium bromoperoxidase as a signal-generating enzyme for chemiluminescent systems: test kits and analytical methods
CN1113105C (zh) 1995-09-01 2003-07-02 奥索临床诊断有限公司 使用钒溴过氧化物酶作为产生信号之酶测定特异性结合配体的分析元件和方法
US6602677B1 (en) * 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
DE69821132T2 (de) * 1997-10-27 2004-10-21 Takeda Chemical Industries Ltd 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
US7118878B1 (en) * 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20030157643A1 (en) * 2000-08-24 2003-08-21 Almond Brian D Synthetic nucleic acids from aquatic species
WO2004071447A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as therapeutic agents
EP1592805A1 (en) * 2003-02-12 2005-11-09 Promega Corporation Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions
US20050187277A1 (en) * 2004-02-12 2005-08-25 Mjalli Adnan M. Substituted azole derivatives, compositions, and methods of use
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
AU2007211319B9 (en) 2006-01-30 2012-05-31 Vtv Therapeutics Llc Substituted imidazole derivatives and their use as PTPase inhibitors
US7977493B2 (en) * 2006-07-28 2011-07-12 Osamu Nozaki Chemiluminescent reagents
US20080248511A1 (en) * 2007-03-26 2008-10-09 Promega Corporation Methods to quench light from optical reactions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278439A (en) * 1979-12-17 1981-07-14 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
AU558939B2 (en) * 1982-03-03 1987-02-12 British Technology Group Limited Enhanced luminescent and luminometric assay
JPS58158542A (ja) * 1982-03-17 1983-09-20 Hitachi Ltd 化学発光増感法
US4659657A (en) * 1982-12-24 1987-04-21 Bayer Aktiengesellschaft Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases
DE3463395D1 (en) * 1983-02-11 1987-06-04 Nat Res Dev Enhanced luminescent or luminometric assay
GB8420053D0 (en) * 1984-08-07 1984-09-12 Secr Social Service Brit Enhanced luminescent/luminometric assay
US4950588A (en) * 1985-07-10 1990-08-21 Molecular Diagnostics, Inc. Prolonged enhanced chemiluminescence
CA1307480C (en) * 1985-07-10 1992-09-15 Nanibhushan Dattagupta Prolonged chemiluminescence
GB8713951D0 (en) * 1987-06-15 1987-07-22 Dewar M H Enhanced chemiluminescent reaction

Also Published As

Publication number Publication date
DE69026851T2 (de) 1996-10-31
DE69026851D1 (de) 1996-06-13
EP0384271B1 (en) 1996-05-08
US5106732A (en) 1992-04-21
ATE137805T1 (de) 1996-05-15
CA2009925A1 (en) 1990-08-14
CA2009925C (en) 2002-10-01
EP0384271A2 (en) 1990-08-29
EP0384271A3 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
ES2086326T3 (es) Metodo para intensificar la quimiluminiscencia.
ES2036551T3 (es) Compuestos heterociclicos.
DK633088A (da) Kollagenaseinhibitorer
DK0479546T3 (da) Piperazinderivater
DK0947504T3 (da) 16-en-vitamin D-derivater
PT90912A (pt) Processo para a preparacao de derivados de tiofenol
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DE3177284D1 (de) Organische phosphinsaeureverbindungen.
LV10433A (lv) Panemiens heksahidroazepina atvasinajumu iegusanai
IT1271711B (it) Derivati della 2,2,6,6-tetrametilpiperidina utili come stabilizzanti alla luce, al calore e all'ossidazione per materiali organici
NO931225D0 (no) Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet
DE3378978D1 (de) Tetrahydro-benzo(e) isoindolines
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
DE69114352T2 (de) Verbesserte chemilumineszierende Reagenzien und Verfahren.
ATE126793T1 (de) Morpholinderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ES2094521T3 (es) Procedimiento para la obtencion de un granulado de tetrahidro-3,5-dimetil-1,3,5-tiadiazin-2-tiona ampliamente exento de polvo.
FI824298L (fi) N,n-disubstituerade alkenamider och fenylalkenamider, deras framstaellningsfoerfaranden och anvaendning som laekemedel
DE3679977D1 (de) Pyran-derivate.
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
DE68914392D1 (de) Verwendung von oxydierten Polyamiden, speziell NN'-Bis-(3-propionaldehyd)-1-4-diaminobutan als Immunsuppressiva.
DK505788D0 (da) Fremgangsmaade til fremstilling af en makrolidforbindelse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 384271

Country of ref document: ES